ADT1722-Zanolimumab Biosimilar-Anti-CD4 mAb-Research Grade
- +1 609-736-0910
- info@alphalifetech.com
- 90 State Street, STE 700 Office 40, Albany, NY 12207 United States
Product Background
Catalog Number |
ADT1722 |
Product Name |
ADT1722-Zanolimumab Biosimilar-Anti-CD4 mAb-Research Grade |
Alternate Names |
human cd4, anti mouse cd4, anti cd4 antibody, cd4 antibody, mouse cd4, anti-cd4 antibody, anti-mouse cd4 antibody, recombinant cd4, anti-cd4 monoclonal antibody, cd4 antibodies, cd4 recombinant antibody, cd4 blocking antibody |
Alias |
HuMax-CD4 |
Clonity |
Monoclonal |
Host |
CHO Cells |
Species |
Human |
Target |
CD4 |
Gene ID |
920 |
Isotype |
IgG1 Kappa |
Size |
1mg, 5mg |
Research Area |
Immunology |
CAS Number |
652153-01-0 |
Product Description |
Zanolimumab (expected trade name HuMax-CD) is a human monoclonal antibody and an immunosuppressive drug. It was developed with the goal of treatment of rheumatoid arthritis, psoriasis, melanoma, cutaneous and peripheral T-cell lymphoma. Development of the drug was ultimately discontinued with termination of all trials. |
Mechanism of Action |
Zanolimumab is a monoclonal antibody targeting CD4. |
Metabolism |
Zanolimumab has a moderate half-life and is distributed throughout the bloodstream and tissues. |
Application |
Neut, ELISA, IF, IP, Functional assay, FC |
Purity |
>95% as determined by SDS-PAGE |
Concentration |
batch dependent |
Buffer |
Supplied in PBS, PH7.5 |
Storage |
Store at -20 °C for 12 months. Store at -80 °C for long term storage. |
Shipping Condition |
Shipped on ice packs. |
Note |
This product is for research use only. |
Reactivity |
Human |
|
Reference 1. Tumba NL, et al. Biochem Biophys Res Commun, 2022 Jul 5. PMID 35550505
2. Wang Z, et al. Nephrol Dial Transplant, 2022 Oct 19. PMID 35104893
3. Wensel D, et al. J Mol Biol, 2022 Jan 30. PMID 34896364
|





